Kevin J. Scanlon, Ph.D.
Founder and CEO

[Arrow] We are at the threshold of a medical revolution for the diagnosis and treatment of human disease. Our Mission at International BioScience is to integrate the Creative Knowledge of Science with the Core Disciplines of Business Development Strategies

[Arrow] Dr. Kevin J. Scanlon's background includes: academic medicine, senior management in the pharmaceutical industry, CEO of four start-up biotechnology companies and an angel investor. Some examples of his experiences includes the following:

  • Dr. Kevin Scanlon is CEO of the stem cell technology company, Makucell. The product, is a small molecule that activates stem cells in human skin. The product, Renewnt, is being sold to dermatologists and direct to consumers in the US, Europe and Asia. Renewnt is one of the safest skin care products on the market. This is based on one of the largest skin trials in the industry. This product is supported by very strong pre-clinical and clinical data.
  • Dr. Kevin Scanlon is the Emeritus Chairman of Pasadena Angels Investment Group. This organization support entrepreneurs with seed round investments for their novel technology. (Investment Community) Read his Entrepreneurial Economy article from the Technolink Association Newsletter in Adobe PDF Format.
  • He is a faculty advisor for graduate business students involved in the UCLA FEMBA Global Access Program ( (Teaching)
  • Dr. Scanlon has worked with entrepreneurs, the investment community and international governments in Ireland, China and New Zealand to create an innovative culture around the intellectual property from their academic institutions. (Events)
  • As a Pharmaceutical Industry-Vice President at Berlex-Schering AG (Berlin, Germany), he was responsible for the company's international cancer program in the US, Europe and Asia. (Industry)
  • Dr. Scanlon received his Ph.D. degree from the University of London in Molecular Biology and trained in Cancer Research at Yale Medical School. He was a Leukemia Society Scholar, awarded the Paul Martini Medical Research Prize in Cancer (Germany), was the past President of the International Society of Cell and Cancer Gene Therapy (England), was a participant at 400th Anniversary of Uppsala University (Sweden), is an advisor for the National Institute for Cellular Biotechnology (Ireland), Co-Founder of Nature’s "Cancer Gene Therapy", co-authored over 137 original scientific articles, edited nine medical books and has seven issued patents. (Science)
BiographyEventsArticlesAngel InvestingBoardsConsultingIndustry
TeachingScienceBiotech CenterPhotosWebcastsLinksContact Us

You are visitor number 172,627 to the KJScanlon website.

Baywalk MarketingTop of Page